NDRG2 expression in breast cancer could reduce PD-L1 expression and restore the T cell proliferation activity suppressed by PD-L1 expression on tumor cells, indicating a possible role of NDRG2 in PD-L1 downregulation. This evidence concerns the gene CD274 and breast carcinoma.